J Microbiol 2008, 46:441–447.PubMedCrossRef 48. Skindersoe ME, Alhede M, Phipps R, Yang L, Jensen PO, Rasmussen TB, Bjarnsholt T, Tolker-Nielsen URMC-099 manufacturer T, Høiby N, Givskov M: Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa . Antimicrob Agents Chemother 2008, 52:3648–3663.PubMedCrossRef 49. Hoffman LR, D’Argenio DA, MacCoss MJ, Zhang Z, Jones RA, Miller SI: Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 2005, 436:1171–1175.PubMedCrossRef 50. Linares JF, Gustafsson

I, Baquero F, Martinez JL: Antibiotics as intermicrobial signaling agents instead of weapons. Proc Natl Acad Sci USA 2006, 103:19484–19489.PubMedCrossRef 51. Whiteley M, Bangera MG, Bumgarner RE, Parsek MR, Teitzel GM, Lory S, Greenberg EP: Gene expression in Pseudomonas aeruginosa biofilms. Nature 2001, 413:860–864.PubMedCrossRef 52. Lujan AM, Moyano AJ, Segura I, Argarana CE, Smania AM: Quorum-sensing-deficient (lasR) mutants emerge at high frequency from a Pseudomonas aeruginosa mutS strain. Microbiology 2007, 153:225–237.PubMedCrossRef 53. Wilder CN, Allada G, Schuster M: Instantaneous within-patient diversity of Pseudomonas aeruginosa quorum-sensing populations from cystic fibrosis lung infections. Infect Immun 2009, 77:5631–5639.PubMedCrossRef 54.

NSC 683864 Winstanley C, Fothergill JL: The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections. FEMS Microbiol Lett 2009, 290:1–9.PubMedCrossRef 55. Kirchner S, Fothergill JL, Wright EA, James CE, Mowat E, Winstanley C: Use of artificial sputum medium to test antibiotic efficacy GSK458 order against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung. J Vis Exp 2012, 64:e3857.PubMed 56. Winstanley C, Langille MG, Fothergill JL, Kukavica-Ibrulj I, Paradis-Bleau C, Sanschagrin F, Thomson NR, Winsor GL, Quail MA, Lennard N, Bignell A, Clarke L, Seeger K, Saunders D, Harris D, Parkhill J, Hancock RE, Brinkman FS, Levesque RC: Newly introduced

genomic prophage islands are critical determinants of in vivo competitiveness in the Pazopanib price Liverpool Epidemic Strain of Pseudomonas aeruginosa . Genome Res 2009, 19:12–23.PubMedCrossRef 57. James C, Fothergill J, Kalwij H, Hall A, Cottell J, Brockhurst M, Winstanley C: Differential infection properties of three inducible prophages from an epidemic strain of Pseudomonas aeruginosa . BMC Microbiol 2012, 12:216.PubMedCrossRef 58. Hedges AJ: Estimating the precision of serial dilutions and viable bacterial counts. Int J Food Microbiol 2002, 76:207–214.PubMedCrossRef 59. Smart CH, Scott FW, Wright EA, Walshaw MJ, Hart CA, Pitt TL, Winstanley C: Development of a diagnostic test for the Midlands 1 cystic fibrosis epidemic strain of Pseudomonas aeruginosa . J Med Microbiol 2006, 55:1085–1091.PubMedCrossRef 60.